Burkholderia pyrrocinia in cystic fibrosis lung transplantation: A case Report

Transplantation Proceedings

Volumn 46, Issue 1, 2014, Pages 295-297

  Savi, D ^a   De Biase, R Valerio ^a   Amaddeo, A ^b   Anile, M ^a   Venuta, F ^a   Ruberto, F ^a   Simmonds, N ^c   Cimino, G ^a   Quattrucci, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CEFTAZIDIME; CYCLOSPORIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DORIPENEM; FLUCONAZOLE; FOSCARNET SODIUM; LINEZOLID; MEROPENEM; METHYLPREDNISOLONE; PIPERACILLIN; PREDNISONE; TACROLIMUS; TEMOCILLIN; TOBRAMYCIN; VALGANCICLOVIR; VANCOMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BURKHOLDERIA INFECTION; BURKHOLDERIA PYRROCINIA; BURKHOLDERIA PYRROCINIA INFECTION; CASE REPORT; CAUSE OF DEATH; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE EXACERBATION; DYSPNEA; EMPYEMA; ENDOTRACHEAL INTUBATION; ESOPHAGUS VARICES; EXTRACORPOREAL OXYGENATION; FEMALE; GENERAL CONDITION DETERIORATION; HEMOFILTRATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCAPNIA; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LIVER DISEASE; LUNG DISEASE; LUNG INSUFFICIENCY; LUNG LAVAGE; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MULTIPLE ORGAN FAILURE; NAUSEA; NUTRITIONAL STATUS; OXYGEN THERAPY; PANCYTOPENIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPSIS; SPUTUM CULTURE; THORAX RADIOGRAPHY; TOPICAL TREATMENT; TREATMENT DURATION; TREMOR; BURKHOLDERIA; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; MICROBIOLOGY; RADIOGRAPHY; RISK; TREATMENT OUTCOME;

ADOLESCENT; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; C-REACTIVE PROTEIN; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; POSTOPERATIVE PERIOD; RISK; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84893530887     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.08.108     Document Type: Article

References (5)

1. A. De Soyza, G. Meachery, and K.L. Hester et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience J Heart Lung Transplant 29 2010 1395 1404
2. T.G. Liu, F.R. Adler, and D. Huang Use of lung transplantation survival models to refine patient selection in cystic fibrosis Am J Respir Crit Care Med 171 2005 1053 1059
3. D.D. Frangolias, E. Mahenthiralingam, and S. Rae et al. Burkholderia cepacia in cystic fibrosis. Variable disease course Am J Respir Crit Care Med 170 1999 1572 1577
4. P. Drevinek, and Mahenthiralingam Burkholderia cenocecepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence Clin Microbiol Infec 16 2010 821 830
5. R.M. Aris, J.C. Routh, and J.J. LiPuma et al. Lung transplantation for cystic fibrosis patients with Bulkholderia cepacia complex: Survival linked to genomovar type Am J Respir Crit Care Med 164 2001 2102 2106